Moderna Takes The Lead With Plan To Tackle New COVID-19 Variants
New Tweaked Booster To Enter Phase I Study
Moderna aims to produce up to 1 billion doses of its existing vaccine in 2021 - but a new booster to target variants will also enter Phase I trials. 
